| Phyllodes tumors of the breast: The British Columbia Cancer Agency experience |
8 |
| Prevalence of burnout, depression and job satisfaction among French senior and resident radiation oncologists |
7 |
| (Ga-68)-PSMA-PET/CT for the detection of postoperative prostate cancer recurrence: Possible implications on treatment volumes for radiation therapy |
6 |
| Management of CNS disease in ALK-positive non-small cell lung cancer: Is whole brain radiotherapy still needed? |
5 |
| Flash radiotheray at very high dose-rate: A brief account of the current situation |
5 |
| Total neoadjuvant therapy for rectal cancer |
5 |
| Combining radiation therapy and cancer immune therapies: From preclinical findings to clinical applications |
5 |
| Combination of radiotherapy and immune treatment: First clinical data |
4 |
| Salvage reirradiation for local prostate cancer recurrence after I radiation therapy. For who? When? How? |
4 |
| Combination of chemotherapy and radiotherapy: A thirty years evolution |
4 |
| Reproducibility of rectal tumor volume delineation using diffusion-weighted MRI: Agreement on volumes between observers |
4 |
| Evaluation of acute skin toxicity of breast radiotherapy using thermography: Results of a prospective single-centre trial |
4 |
| Reference bases of radiotherapy under stereotaxic conditions for bronchopulmonary, hepatic, prostatic, upper aero-digestive, cerebral and bone tumors or metastases |
4 |
| Radiation-induced head and neck pain: Management with botulinum toxin a injections |
4 |
| Contouring workload in adjuvant breast cancer radiotherapy |
4 |
| Use of nanoparticles as radiosensitizing agents in radiotherapy: State of play |
4 |
| Brachytherapy boost for prostate cancer: A national survey from Groupe curietherapie - Societe francaise de radiotherapie oncologique |
3 |
| Effects of health education intervention on negative emotion and quality of life of patients with laryngeal cancer after postoperative radiotherapy |
3 |
| A low gradient junction technique of craniospinal irradiation using volumetric-modulated arc therapy and its advantages over the conventional therapy |
3 |
| Construction and clinical evaluation of a new customized bite block used in radiotherapy of head and neck cancer |
3 |
| Anti-PD-1 immunotherapy in combination with sequential involved-site radiotherapy in heavily pretreated refractory Hodgkin lymphoma |
3 |
| (F-18)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy |
3 |
| Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendations |
3 |
| Relationship between nutritional status and esophageal fistula formation after radiotherapy for esophageal cancer |
3 |
| Place of radiotherapy and surgery in the treatment of cervical cancer patients |
3 |
| Effects of high-dose irradiation on vascularization: Physiopathology and clinical consequences |
3 |
| Radiobiology of brachytherapy: The historical view based on linear quadratic model and perspectives for optimization |
2 |
| Place of modern imaging in brachytherapy planning |
2 |
| 3D brachytherapy for cervical cancer: New optimization ways |
2 |
| Evaluation of an automatic delineation system for organs at risk and target lymph nodes volumes for patients treated for breast cancer |
2 |
| Adaptive radiotherapy: Strategies and benefits depending on tumor localization |
2 |
| Overview of adaptive radiotherapy in 2019: From implementation to clinical use |
2 |
| Proton therapy in France in 2019 |
2 |
| Cancer of the oesophagus and lymph nodes management in the neoadjuvant or definitive radiochemotherapy setting |
2 |
| Whole breast radiotherapy in the isocentric lateral decubitus position: Role of the immobilization device and table on clinical results |
2 |
| Physiopathology and pharmacological perspectives in the treatment of radiation enteritis |
2 |
| Radiotherapy of relapse-refractory follicular lymphoma |
2 |
| Adjuvant radiotherapy for positive lymph nodes of oesophageal squamous cell carcinoma: Can it earn promising benefits at long-term follow-up? |
2 |
| Trimodalities for bladder cancer in elderly: Transurethral resection, hypofractionated radiotherapy and gemcitabine |
2 |
| Multimodality imaging using PET/CT (F-18)-fluorodeoxyglucose for radiotherapy field delineation of localized Hodgkin lymphoma |
2 |
| Role of FDG PET-CT in the treatment management of Hodgkin lymphoma |
2 |
| Three-year results after radiotherapy for locally advanced sinonasal adenoid cystic carcinoma, using highly conformational radiotherapy techniques proton therapy and/or Tomotherapy |
2 |
| Pharmacological modulation of radiation-induced oral mucosal complications |
2 |
| Toxicity of docetaxel, platine, 5-fluorouracil-based induction chemotherapy for locally advanced head and neck cancer: The importance of nutritional status |
2 |
| Which alpha/beta ratio for prostate cancer in 2019? |
2 |
| The sentinel lymph node of breast cancer and the radiation oncologist |
2 |
| New developments in the management of nasopharyngeal carcinoma |
2 |
| Definition of target volume: When et how can the radiation oncologist use PET? |
2 |
| PET and MRI based RT treatment planning: Handling uncertainties |
2 |
| Use of 4D-CT for radiotherapy planning and reality in France: Data from a national survey |
2 |
